Description

Product Description

Oxaliplatin is a chemically stable, third-generation platinum complex featuring a 1,2-diaminocyclohexane (DACH) carrier ligand and oxalate leaving group. Its structure confers distinct pharmacological and cytotoxic profiles compared to cisplatin and carboplatin. As a laboratory research compound, Oxaliplatin is instrumental in investigating DNA damage response, cell cycle regulation, and apoptosis in cancerous cells.

Oxaliplatin exerts its antitumor activity primarily by forming covalent platinum-DNA adducts. These adducts lead to intra- and interstrand DNA crosslinks, interfering with DNA replication and transcription. As a result, cells activate DNA repair pathways, including nucleotide excision repair (NER) and mismatch repair (MMR). If damage persists, signaling cascades trigger programmed cell death via intrinsic and extrinsic apoptotic pathways.

In vitro studies reveal that Oxaliplatin induces cytotoxicity across a range of human cancer cell lines, including colorectal, gastric, pancreatic, and ovarian models. Its DACH ligand is believed to confer reduced susceptibility to cellular detoxification mechanisms such as glutathione conjugation, enhancing activity against cisplatin-resistant cells. Researchers also report that Oxaliplatin synergizes with other cytotoxic agents, targeted therapies, and immunomodulators, expanding its utility in combination experiments.

Oxaliplatin demonstrates dose-dependent effects in experimental systems. Low concentrations may induce DNA damage signaling without immediate apoptosis, providing opportunities to study repair mechanisms, stress responses, and senescence. Higher concentrations typically result in robust apoptotic induction, characterized by caspase activation, mitochondrial depolarization, and PARP cleavage. These effects can be measured using assays such as flow cytometry, western blotting, immunofluorescence, and cell viability studies.

From a biochemical perspective, Oxaliplatin’s oxalate leaving group is highly water-soluble, facilitating in vitro formulation. The DACH carrier ligand contributes to the formation of bulky DNA adducts, which are less efficiently repaired by the nucleotide excision repair system, potentially explaining its efficacy in certain resistant cancer models. In laboratory research, Oxaliplatin is usually dissolved in aqueous solvents or DMSO, with careful handling to prevent hydrolysis and preserve activity.

Researchers frequently employ Oxaliplatin to study mechanisms of chemoresistance. Resistance pathways include enhanced DNA repair, increased drug efflux via transporters (e.g., MRP2), alterations in apoptotic signaling, and elevated intracellular detoxification. Experimental manipulation of these pathways with Oxaliplatin allows investigation into novel therapeutic strategies, predictive biomarkers, and combination approaches designed to overcome resistance in tumor models.

Experimental research also explores Oxaliplatin-induced immunogenic cell death. Certain cancer cell populations treated with Oxaliplatin release damage-associated molecular patterns (DAMPs) such as calreticulin, HMGB1, and ATP, which can stimulate dendritic cells and T-cell responses. This property is particularly useful for studies combining chemotherapeutics with immunotherapy and for understanding tumor microenvironment interactions.

Oxaliplatin has a well-characterized safety and handling profile in laboratory settings. It is cytotoxic to both cancerous and non-cancerous cells at research concentrations, necessitating the use of appropriate protective equipment, biosafety cabinets, and disposal protocols. Standard precautions include gloves, lab coats, and eye protection. Solutions should be prepared fresh or stored under conditions that prevent decomposition, typically at 2–8°C and shielded from light.

Oxaliplatin’s versatility in laboratory research extends beyond oncology. Investigations into DNA repair pathways, epigenetic modifications, and oxidative stress responses often employ Oxaliplatin as a chemical tool to induce controlled DNA damage. It can be used in combination with gene editing technologies, RNA interference, and high-content imaging to study cellular responses in precise experimental contexts.

Overall, Oxaliplatin is a critical platinum-based reagent for experimental oncology, pharmacology, and molecular biology. Its distinct DACH platinum complex structure, potent cytotoxicity, and capacity to induce DNA damage and immunogenic cell death make it an indispensable agent for cancer research laboratories worldwide.

Product Specifications

Mechanism of Action

Oxaliplatin’s antineoplastic activity primarily involves DNA crosslinking and adduct formation, which disrupts replication and transcription. The platinum center reacts with the N7 position of guanine and adenine bases, creating intra- and interstrand crosslinks. These structural distortions prevent proper DNA replication, activating DNA damage response pathways.

DNA Damage Response

The formation of platinum-DNA adducts triggers a cascade of repair mechanisms, including nucleotide excision repair (NER) and mismatch repair (MMR). Persistent lesions activate p53 signaling, cell cycle checkpoints, and apoptosis. Laboratory research can measure γ-H2AX foci formation, a hallmark of double-strand break signaling, to quantify DNA damage.

Cell Cycle Arrest

Oxaliplatin treatment induces G2/M phase arrest in cultured cancer cells. This checkpoint activation allows cells to attempt DNA repair. If repair fails, cells proceed to apoptosis. This property is used to study checkpoint regulation and mechanisms of chemoresistance.

Apoptosis Induction

Oxaliplatin activates both intrinsic (mitochondrial) and extrinsic apoptotic pathways. Key events include mitochondrial membrane depolarization, cytochrome c release, caspase-3 and -9 activation, and PARP cleavage. These molecular events are commonly quantified using western blot, flow cytometry, and fluorescence microscopy in experimental settings.

Immunogenic Cell Death

Oxaliplatin can trigger immunogenic cell death (ICD) in vitro. Treated cells release DAMPs, such as calreticulin exposure on the cell surface, ATP secretion, and HMGB1 release, enhancing dendritic cell maturation and T-cell activation. Researchers use these effects to study tumor immunology and combination therapies with checkpoint inhibitors.

Resistance and Synergy

Cellular resistance to Oxaliplatin involves enhanced DNA repair, drug efflux transporters, and anti-apoptotic signaling. Experimental studies often combine Oxaliplatin with inhibitors of DNA repair enzymes, modulators of oxidative stress, or targeted therapies to evaluate synergistic effects and overcome chemoresistance.

Experimental Applications

In vitro, Oxaliplatin is used to study:

• DNA crosslink formation and repair kinetics

• Apoptosis signaling pathways

• Chemoresistance mechanisms

• Drug combination effects

• Tumor microenvironment interactions and immunogenic responses

These applications make it a valuable reagent in oncology, molecular biology, and pharmacology research.

Side Effects

In laboratory research, Oxaliplatin exhibits cytotoxicity toward both tumor and normal cells. Side effects observed in in vitro studies include:

• DNA damage–induced cytotoxicity: Leads to apoptosis and reduced cell viability.

• Oxidative stress: Increased reactive oxygen species (ROS) may damage cellular components.

• Cell cycle perturbation: Arrest in G2/M phase can impact proliferation assays.

• Neurotoxicity markers in neuronal cultures: Oxaliplatin may induce axonal degeneration and mitochondrial dysfunction in experimental neuronal models.

• Hypersensitivity responses in immune cell assays: Activation of immune pathways due to ICD can affect co-culture experiments.

Proper handling, including the use of gloves, lab coats, biosafety cabinets, and proper waste disposal, is critical to ensure safety in experimental settings. Solutions should be freshly prepared or stored under recommended conditions (2–8°C, light-protected) to preserve bioactivity.

Keywords

Oxaliplatin, platinum-based chemotherapeutic, DNA crosslinking, apoptosis, chemoresistance research, immunogenic cell death, anticancer research, colorectal cancer research, ovarian cancer models, high-purity laboratory reagent

Shipping Guarantee

All shipments are handled using validated cold-chain logistics to preserve compound integrity. Each package is sealed in moisture-proof containers with secondary protective wrapping and continuous temperature monitoring. Products are shipped via express international couriers with full tracking and insurance coverage.

Trade Assurance

We ensure product authenticity, verified ≥99% purity, and compliance with analytical standards (HPLC, MS, and NMR). Each batch is supplied with a Certificate of Analysis (CoA). Our trade assurance policy guarantees replacement or refund for any deviation from listed specifications.

Payment Support

We provide flexible and secure global payment options to support international research transactions. Accepted payment methods include PayPal, major credit cards (Visa, MasterCard, American Express), telegraphic transfer (T/T), and cryptocurrencies (USDT, Bitcoin, Ethereum). All transactions are protected by industry-standard encryption and verified payment gateways to ensure confidentiality and fund security.

Disclaimer

All products listed are intended for laboratory research use only and not for human or veterinary use. They are not drugs, medical devices, or diagnostics and should not be administered to humans or animals. Researchers must handle all materials in accordance with institutional biosafety and chemical safety guidelines. The information provided is for scientific reference only and does not imply therapeutic efficacy, safety, or regulatory approval.